Boehringer Ingelheim
Browse

Supplemental materials for DINAMO MONO manuscript

Download (153.62 kB)
dataset
posted on 2025-06-03, 05:28 authored by Lori M Laffel, Thomas Danne, Georgeanna J. Klingensmith, Elke Schueler, Igor Tartakovsky, Laurieann Nessralla, Philip Zeitler, Steven Willi

This is the supplemental material for the publication 'A comparison of SGLT2 or DPP-4 inhibitor monotherapy vs placebo for type 2 diabetes in adolescents vs young adults ' in the journal JES.

Funding

The DINAMO and DINAMO MONO trials (NCT03429543), as well as the young adults trial (NCT01177813) were funded by the Boehringer Ingelheim and Eli Lilly and Company Alliance.

History

Usage metrics

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC